The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics
Open accessAbstract
Mitochondrial dysfunctions cause numerous human disorders. A platform technology based on biodegradable polymers for carrying bioactive molecules to the mitochondrial matrix could be of enormous potential benefit in treating mitochondrial diseases. Here we report a rationally designed mitochondria-targeted polymeric nanoparticle (NP) system and its optimization for efficient delivery of various mitochondria-acting therapeutics by blending a targeted poly( d , l -lactic- co -glycolic acid)-block (PLGA- b )-poly(ethylene glycol) (PEG)-triphenylphosphonium (TPP) polymer (PLGA- b -PEG-TPP) with either nontargeted PLGA- b -PEG-OH or PLGA-COOH. An optimized formulation was identified through in vitro screening of a library of charge- and size-varied NPs, and mitochondrial uptake was studied by qualitative and quantitative investigations of cytosolic and mitochondrial fractions of cells treated with blended NPs composed of PLGA- b -PEG-TPP and a triblock copolymer containing a fluorescent quantum dot, PLGA- b -PEG-QD. The versatility of this platform was demonstrated by studying various mitochondria-acting therapeutics for different applications, including the mitochondria-targeting chemotherapeutics lonidamine and α-tocopheryl succinate for cancer, the mitochondrial antioxidant curcumin for Alzheimer’s disease, and the mitochondrial uncoupler 2,4-dinitrophenol for obesity. These biomolecules were loaded into blended NPs with high loading efficiencies. Considering efficacy, the targeted PLGA- b -PEG-TPP NP provides a remarkable improvement in the drug therapeutic index for cancer, Alzheimer’s disease, and obesity compared with the nontargeted construct or the therapeutics in their free form. This work represents the potential of a single, programmable NP platform for the diagnosis and targeted delivery of therapeutics for mitochondrial dysfunction-related diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Targeting mitochondria for cancer therapy
Fulda, S., Galluzzi, L., & Kroemer, G. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3137 · Cited by 1,629
Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro
Ono, K., Hasegawa, K., Naiki, H., & Yamada, M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20025 · Cited by 1,254
Hrkach, J., Von Hoff, D., Ali, M. M., Andrianova, E., Auer, J., Campbell, T., De Witt, D., Figa, M., Figueiredo, M., Horhota, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003651 · Cited by 1,147
Chloride Accumulation and Swelling in Endosomes Enhances DNA Transfer by Polyamine-DNA Polyplexes
Sonawane, N. D., Szoka, F. C., & Verkman, A. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308643200 · Cited by 1,081
Dhar, S., Gu, F. X., Langer, R., Farokhzad, O. C., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809154105 · Cited by 994
Self-citationDelivery of bioactive molecules to mitochondria in vivo
Smith, R. A. J., Porteous, C. M., Gane, A. M., & Murphy, M. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931245100 · Cited by 725
Mitochondria in health and disease: perspectives on a new mitochondrial biology
Duchen, M. R. (2004) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2004.03.001 · Cited by 721
Kolishetti, N., Dhar, S., Valencia, P. M., Lin, L. Q., Karnik, R., Lippard, S. J., Langer, R., & Farokhzad, O. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011368107 · Cited by 565
Self-citationWang, L., Liu, Y., Li, W., Jiang, X., Ji, Y., Wu, X., Xu, L., Qiu, Y., Zhao, K., Wei, T., et al. (2011) · Nano Letters · doi:10.1021/nl103992v · Cited by 514
Dhar, S., Kolishetti, N., Lippard, S. J., & Farokhzad, O. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011379108 · Cited by 513
Self-citationTargeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma
Agemy, L., Friedmann-Morvinski, D., Kotamraju, V. R., Roth, L., Sugahara, K. N., Girard, O. M., Mattrey, R. F., Verma, I. M., & Ruoslahti, E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114518108 · Cited by 347
Platinum nanoparticle is a useful scavenger of superoxide anion and hydrogen peroxide
Kajita, M., Hikosaka, K., Iitsuka, M., Kanayama, A., Toshima, N., & Miyamoto, Y. (2007) · Free Radical Research · doi:10.1080/10715760601169679 · Cited by 301
Mitochondrial gateways to cancer
Galluzzi, L., Morselli, E., Kepp, O., Vitale, I., Rigoni, A., Vacchelli, E., Michaud, M., Zischka, H., Castedo, M., & Kroemer, G. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.08.002 · Cited by 300
Antioxidant-potentiality of gold–chitosan nanocomposites
Esumi, K., Takei, N., & Yoshimura, T. (2003) · Colloids and Surfaces B Biointerfaces · doi:10.1016/s0927-7765(03)00151-6 · Cited by 234
Boddapati, S. V., D’Souza, G. G. M., Erdogan, S., Torchilin, V. P., & Weissig, V. (2008) · Nano Letters · doi:10.1021/nl801908y · Cited by 234
Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells.
Floridi, A., Paggi, M. G., Marcante, M. L., Silvestrini, B., Caputo, A., & Martino, C. D. (1981) · PubMed · Cited by 211
Mulik, R. S., Mönkkönen, J., Juvonen, R. O., Mahadik, K. R., & Paradkar, A. R. (2010) · Molecular Pharmaceutics · doi:10.1021/mp900306x · Cited by 164
Small mitochondria-targeting molecules as anti-cancer agents
Wang, F., Ogasawara, M. A., & Huang, P. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.12.003 · Cited by 143
Liu, J., Shen, W., Zhao, B., Wang, Y., Wertz, K., Weber, P., & Zhang, P. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.06.007 · Cited by 143
Neužil, J., Dyason, J. C., Freeman, R., Dong, L., Procházka, L., Wang, X., Scheffler, I. E., & Ralph, S. J. (2007) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-006-9060-z · Cited by 130
Beletsi, A., Panagi, Z., & Avgoustakis, K. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.024 · Cited by 128
Chalmers, S., Caldwell, S. T., Quin, C., Prime, T. A., James, A. M., Cairns, A. G., Murphy, M. P., McCarron, J. G., & Hartley, R. C. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2077922 · Cited by 128
Paunesku, T., Vogt, S., Lai, B. C. H., Maser, J. M., Stojićević, N., Thurn, K. T., Osipo, C., Liu, H. S., Legnini, D. G., Wang, Z., et al. (2007) · Nano Letters · doi:10.1021/nl0624723 · Cited by 117
Sharma, A., Soliman, G. M., Al‐Hajaj, N., Sharma, R. B., Maysinger, D., & Kakkar, A. K. (2011) · Biomacromolecules · doi:10.1021/bm201538j · Cited by 111
Platinum nanoparticles have an activity similar to mitochondrial NADH:ubiquinone oxidoreductase
Hikosaka, K., Kim, J., Kajita, M., Kanayama, A., & Miyamoto, Y. (2008) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2008.06.008 · Cited by 92
Mitochondria-targeted liposomes improve the apoptotic and cytotoxic action of sclareol
Patel, N. R., Hatziantoniou, S., Georgopoulos, A., Demetzos, C., Torchilin, V. P., Weissig, V., & D’Souza, G. G. M. (2009) · Journal of Liposome Research · doi:10.3109/08982100903347931 · Cited by 81
Blaikie, F. H., Brown, S. E., Samuelsson, L. M., Brand, M. D., Smith, R. A. J., & Murphy, M. P. (2006) · Bioscience Reports · doi:10.1007/s10540-006-9018-8 · Cited by 65
Cited by
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824
Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy
Pham, T. C., Nguyen, V.-N., Choi, Y., Lee, S., & Yoon, J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00381 · Cited by 1,813
Zielonka, J., Joseph, J., Sikora, A., Hardy, M., Ouari, O., Vasquez-Vivar, J., Cheng, G., Lopez, M., & Kalyanaraman, B. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00042 · Cited by 1,683
Barua, S., & Mitragotri, S. (2014) · Nano Today · doi:10.1016/j.nantod.2014.04.008 · Cited by 1,257
Metadata
- Authors
- Marrache, S., & Dhar, S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2012-09-18
- Volume
- 109
- Issue
- 40
- Pages
- 16288-16293
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2149959721
- Cited by
- 497
- References
- 28
- FWCI
- 13.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.